MGRX
Mangoceuticals Inc (MGRX)
Healthcare • NASDAQ • $0.41+20.85%
- Symbol
- MGRX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $0.41
- Daily Change
- +20.85%
- Market Cap
- $6.97M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $2.75
- 52W Low
- $0.16
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 2.12
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www…
Company websiteResearch MGRX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.